Global and Regional sales ($m) of cancer

cytostatics (chemicals) compounds (2000

to 2010) Report

Author: Philippe Tramoy

Date: 1 February 2010

“Copyright 2010 CBDM.T SARL - Market and Business Intelligence. All rights reserved. Any unauthorized use or disclosure is
prohibited. The information herein was obtained from various sources; we do not guarantee its accuracy or completeness.
This research report is prepared for general circulation and is circulated for general information only. It does not have
regard to specific investment objectives, financial situation and the particular needs of any particular person who may
receive this report. Investors should seek financial advice regarding the appropriateness of investing in any securities or
investment and trading strategies discussed or recommended in this report and should understand that the statements
regarding future prospects may not be realized. Investors should note that income from such securities, if any, may
fluctuate and that each security's price or value may rise or fall. Accordingly, investors may receive back less than originally
invested. Past performance is not necessarily a guide to future performance. Neither the information nor any opinion
expressed constitutes an offer to buy or sell any securities or options or futures contracts. CBDM.T - Market and Business
Intelligence accepts no responsibility or liability whatsoever for any expense, loss or damages arising out of or in any way
connected with the use of all or any part of this report. CBDM.T SARL does not have long or short position in any securities
or options of this issue(s)."
Table of Content

I. Global Anticancer Sales ($m)....................................................................................................... 2

II. Global Cytostatics (chemicals) Anticancer Sales ($m) ................................................................. 3

III. Cytostatics (chemicals) Anticancer Regional Relative Shares (value; percentage) ..................... 4

IV. Regional Cytostatics (chemicals) Anticancer Sales ($m) according to two different

formulations ............................................................................................................................................ 5

V. Regional Cytostatics (chemicals) Anticancer Sales ($m) according to two different

formulations ............................................................................................................................................ 6

VI. Addendum: Global Sales ($m) of Selected Anticancer compounds ............................................ 7

CBDM.T® - Market & Business Intelligence © 2010 1/8